GENE ONLINE|News &
A Novel Tool to Augment Checkpoint Inhibitor Cancer Therapy
Washington University School of Medicine researchers uncover the mechanism by which tumor-infiltrating myeloid cells create suppressive microenvironments. The findings provide a novel approach for augmenting the effects of checkpoint blockade therapies.
The suppressive tumor environment affects T cell responses by engaging immune checkpoint proteins such as PD-1.
GO Prime with only $1.49 now
LATEST
BIO 2023 Coming to Boston, with Over 60 Taiwanese Organizations to Share their Achievements
2023-06-02
2023 ASGCT Annual Meeting: Showcase of Exciting New Research, with a Focus on Clinical Applications
2023-06-02
EVENT
2023-06-05
Redefining Early Stage Investments (RESI) 2023 conference series – RESI Boston
Boston, USA
